Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

著者: Alasdair Coles, Cary Twyman, Douglas L. Arnold, Jeffrey Cohen, Christian Confavreux, Edward Fox, Hans-Peter Hartung, Eva Havrdová, Krzysztof Selmaj, Howard L. Weiner, Tamara Miller, Elizabeth Fisher, Rupert Sandbrink, Stephen Lake, David Margolin, Pedro Oyuela, Michael Panzara, D. A. S. Compston - The Lancet 2012 被引用: 1,193